Johnson & Johnson has kicked off a marketing application in the US for TAR-200 as a treatment for a form of bladder cancer, using a novel technology that releases the drug intravesically, or directly ...
Johnson & Johnson has brought its bladder cancer drug TAR-200 to the US market, a year after its prospects were dented by a negative phase 3 readout. The novel formulation of the stalwart ...
ESPN's Bracketology efforts are focused on projecting the NCAA tournament field just as we expect the NCAA Division I basketball committee to select the field in March. ESPN bracketologist Joe Lunardi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback